Sabaa International Company for Pharmaceutical and Chemical
- 2.81 EGP
- -0.01
- -0.35%
Sabaa International Company for Pharmaceutical and Chemical Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 2.81 |
| Prev. Close | 2.820 |
| Day Range | 2.78 - 2.83 |
| 52WK range | |
| Turnover (M EGP) | 4.27 |
| Volume (M) | 1.52 |
| Number of Trades | 351 |
| Market Cap (M EGP) | 702.50 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 2.78 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Sabaa Pharmaceutical's shareholders approve capital...
Cairo – Mubasher: The extraordinary general meeting (EGM) of Sabaa International Company for Pharmaceutical and Chemical Industry approved the board’s...
FRA approves Sabaa Pharmaceutical's capital raise
Cairo – Mubasher: The Egyptian Financial Regulatory Authority (FRA) approved the publication of the disclosure form submitted by Sabaa International...
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial...
Cairo – Mubasher: The net profits of Sabaa International Company for Pharmaceutical and Chemical Industry jumped by 76% year-on-year (YoY) to EGP...
Sabaa expected to produce 250K doses of Favipiravir...
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry is expected to produce 250,000 doses of Favipiravir for the...
Sabaa Pharmaceutical obtains initial approval to register...
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry has received an initial approval from the Egyptian Drug Authority...
